Yuyu Pharma Competitors and Similar CompaniesClear all

Yuyu Pharma's competitors and similar companies include AOP Orphan Pharmaceuticals, Grupo Menarini, Medochemie and Quantum Pharmaceutical.

	Yuyu Pharma Yuyu Pharma (유유제약, formerly known as YuYu) is a company that manufactures, distributes, and develops medicines.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	Medochemie Medochemie is a pharmaceutical company.	Quantum Pharmaceutical Quantum Pharmaceutical is a manufacturer and supplier of unlicensed medicines and hard-to-source products.
Founding Date	Founding Date 1941	Founding Date 1996	Founding Date 1961	Founding Date 1976	Founding Date 2004
Type	Type Public	Type Private	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Seoul, KR HQ Anyang, KR Bucheon, KR Busan, KR Changwon Si, KR Daegu, KR Daejeon, KR see more	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Badalona, ES HQ	Locations Λεμεσός, CY HQ Ben Aknoun, DZ Amman, JO Rīga, LV Chișinău, MD Moscow, RU	Locations Hobson, GB HQ
Employees	Employees 253	Employees 5352% increase	Employees 5541% increase	Employees 825	Employees 4548% increase
Financial
Revenue (est.)	Revenue (est.) ₩137.2b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £76.1m (FY, 2018)
Cost of goods	Cost of goods ₩85.1b (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods £54.5m (FY, 2018)
Gross profit	Gross profit ₩53.4b (FY, 2023)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit £21.6m (FY, 2018)
Net income	Net income (₩5.5b) (FY, 2023)	Net income N/A	Net income N/A	Net income N/A	Net income (£8.3m) (FY, 2018)